Associate Professor, Medicine, Boston University School of Medicine
Endocrinology
Dr. Shehzad S. Basaria, MD
|
|
Give Review
Shehzad Basaria works in the field of Endocrinology. He attended Aga Khan Medical College. Shehzad S. Basaria is a published doctor and has 102 publications published. The lastest was: 'Images in clinical medicine. Liver abscess with septic pulmonary emboli.'
Publications
- Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial.
- Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Cli...
- Association of sex hormones with sexual function, vitality, and physical function of Symptomatic older men with low testosterone levels at baseline in the testosterone...
- The Effects of Short-Term and Long-Term Testosterone Supplementation on Blood Viscosity and Erythrocyte Deformability in Healthy Adult Mice.
- Effects of testosterone replacement in men with opioid-induced androgen Deficiency: a randomized controlled trial.
- Testosterone Dose-Response Relationships with Cardiovascular Risk Markers in Androgen-Deficient Women: A Randomized, Placebo-Controlled Trial.
- Sildenafil increases serum testosterone levels by a direct action on the testes.
- Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point.
- Male hypogonadism.
- Testosterone Therapy in Older Men with Late-Onset Hypogonadism: A Counter-Rationale.
- Need for standardising adverse event reporting in testosterone trials.
- Reproductive aging in men.
- Risks and benefits of testosterone therapy in older men.
- The effect of testosterone on mood and well-being in men with erectile Dysfunction in a randomized, placebo-controlled trial.
- Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation.
- The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.
- Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic Diseases.
- The heart of stone.
- Hypogonadism and androgen replacement therapy in elderly men.
- Ectopic lingual thyroid masquerading as thyroid cancer metastases.
- Auto-TIPS.
- Apoplexy in a recurrent pituitary adenoma.
- Gastrointestinal bleeding in a woman with pulmonary tuberculosis.
- Renal and extrarenal autosomal dominant polycystic kidney Disease.
- Case in point. Cerebral toxoplasmosis.
- Case of an ivory vertebra.
- Corticotropin-independent Cushing's Syndrome caused by an ectopic adrenal adenoma.
- Images in medicine. Lingual thyroid.
- Link between Diabetes and osteoporosis.
- A rare pituitary lesion.
- Treatment of Hyperlipidemia in women.
- Graves' Disease and recurrent ectopic thyroid tissue.
- Case in point. Scratch purpura of amyloid.
- Risks versus benefits of testosterone therapy in elderly men.
- Ventricular septal defect patch causing right ventricular inflow tract obstruction.
- Images in clinical medicine. Liver abscess with septic pulmonary emboli.
- Interferon-alpha-induced transient severe hypothyroidism in a patient with Graves'' Disease.
- Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves'' Disease.
- Strengthening primary health care and family planning services in Pakistan: some critical issues.
- Andropause: to treat or not to treat?
- Andropause: need for concrete guidelines until more evidence becomes available.
- Metastatic renal cell carcinoma to the pituitary presenting with hyperprolactinemia.
- Necrobiosis lipoidica Diabeticorum: response to pentoxiphylline.
- Acute changes in circulating hormones in older patients with impaired ventricular function undergoing on-pump coronary artery bypass grafting.
- Sex hormone binding globulin levels across the adult lifespan in women--the role of body mass index and fasting insulin.
- Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy.
- The relationship between testosterone and molecular markers of inflammation in older men.
- The hormonal pathway to frailty in older men.
- Preventing skeletal complications in androgen deprived men with prostate cancer: Time for action.
- Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women.
- Welcoming low testosterone as a cardiovascular risk factor.
- Androgens and erythropoiesis: past and present.
- Prostate cancer: cardiovascular mortality and androgen deprivation.
- Endogenous sex steroid hormones and measures of chronic kidney Disease (CKD) in a nationally representative sample of men.
- Estradiol and metabolic Syndrome in older italian men: The InCHIANTI Study.
- Estradiol and inflammatory markers in older men.
- Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women.
- Circulating inflammatory cytokine expression in men with prostate cancer undergoing androgen deprivation therapy.
- Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study).
- Visual vignette. Adrenal myelolipoma.
- Syncope in a transsexual Male.
- Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.
- Clinical Meaningfulness of the Changes in Muscle Performance and Physical Function Associated With Testosterone Administration in Older Men With Mobility Limitation.
- The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III).
- Diagnosis and treatment of hypogonadism in men.
- SHBG, sex hormones, and inflammatory markers in older women.
- Gonadal status and physical performance in older men.
- High-dose isoflavones do not improve metabolic and inflammatory parameters in androgen-deprived men with prostate cancer.
- Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis.
- Testosterone undecanoate in the treatment of Male hypogonadism.
- Adverse events associated with testosterone administration.
- The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men.
- Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study.
- Successful radiation therapy for cerebral metastatic lesions from a pheochromocytoma.
- Emerging cardiometabolic complications of androgen deprivation therapy.
- Androgen abuse in athletes: detection and consequences.
- Safety and efficacy of testosterone gel in the treatment of Male hypogonadism.
- Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy.
- Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth.
- Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men.
- Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis.
- The association of urinary cadmium with sex steroid hormone concentrations in a general population sample of US adult men.
- Testosterone making an entry into the cardiometabolic world.
- The latest options and future agents for treating Male hypogonadism.
- Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study.
- Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III).
- Relation between duration of androgen deprivation therapy and degree of insulin resistance in men with prostate cancer.
- Androgens and Diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III).
- Association between hormones and metabolic Syndrome in older Italian men.
- Endocrine complications of androgen-deprivation therapy in men with prostate cancer.
- Suppurative thyroiditis.
- Emerging drugs for hypogonadism.
- Elderly woman with hypercalcemia and neck mass.
- Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women.
- Association of hormonal dysregulation with metabolic Syndrome in older women: data from the InCHIANTI study.
- Metabolic Syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.
- Low testosterone levels and the risk of anemia in older men and women.
- Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men.
- Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer.
- A Subset of Men with Age-Related Decline in Testosterone have Gonadotroph Autoantibodies.
- Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men.
Schools
Aga Khan University Aga Khan Medical College
The University Of Texas Health
University Tex
John Hopkins University School
Johns Hopkins University School Med
Conditions Treated
- Diabetes Type 2
- Diabetic Retinopathy
- Goiter
- Graves' Disease
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Neighborhood Health Plan
- Tufts Health Plans
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Johns Hopkins University -
University of Texas Health Science Center -
Aga Khan Medical College
Hospital
-
Brigham and Women's Hospital -
Boston Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699730101 |
| Last Name Of The Provider | BASARIA |
| First Name Of The Provider | SHEHZAD |
| View All |
Similar Doctors
|
|
Dr. Ellen W. Seely, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin J. Abrahamson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura H. Zemany, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leslie S. Eldeiry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gilbert H. Daniels, MD
This Doctor is OpenDoctor Recommended.
|